PATENT CLAIM ANALYSIS

Application Number: 16113661
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "407000"]

Abstract:
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.

Claim (Index 22):
The method of  claim 16 , wherein the compound is or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 96.0
- Lexical Diversity: 1.79487
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16063542', '16113533', '16109162', '15762367', '16109223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8035721691227028
- 35 USC 102 Novelty (BERT): 0.5705367974833662
- Combined Prediction Score: 0.7802686319587692
- Mean Citation Score: 411.0168380000002
- Max Citation Score: 453.5731
- Similarity Product: 415.60667891714576

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test